Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome.
about
Prospects of immune checkpoint modulators in the treatment of glioblastomaImmune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know.Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy.Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors.Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients.Imaging Manifestations of Pseudoprogression in Metastatic Melanoma Nodes Injected with Talimogene Laherparepvec: Initial Experience.Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study.Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test.Merkel cell carcinoma in the age of immunotherapy: Facts and hopes.Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer.
P2860
Q28081371-F5857701-5D18-4CD7-8A16-B3D2373AD995Q37589557-96365B14-CFCE-43C5-B520-4A99B7326CB9Q38630561-351AAEE3-65B3-48E9-8287-E7605F63BFB9Q38852974-9D097B80-C6AB-49C7-878E-4E899A13B08DQ38870929-D616CBD8-6C73-447C-BC03-05AC8E23079DQ39746034-9D67115C-26F9-4266-9F99-6BF1901FC17FQ40233749-8AB87DCA-6C2B-4A2C-BFC6-986FAE4BB796Q40420515-D140D5D0-2757-4777-8990-53E114940F16Q41557948-98B9C1E8-31D0-436F-86B2-F85E6CDCF1D0Q47348356-B7E441B2-B0FA-4349-85D5-C9A2BDE2F3A7Q47350013-06875E96-B4BF-40A3-AFAB-859A3EA0C735
P2860
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Response assessment in metasta ...... kers for response and outcome.
@ast
Response assessment in metasta ...... kers for response and outcome.
@en
Response assessment in metasta ...... kers for response and outcome.
@nl
type
label
Response assessment in metasta ...... kers for response and outcome.
@ast
Response assessment in metasta ...... kers for response and outcome.
@en
Response assessment in metasta ...... kers for response and outcome.
@nl
prefLabel
Response assessment in metasta ...... kers for response and outcome.
@ast
Response assessment in metasta ...... kers for response and outcome.
@en
Response assessment in metasta ...... kers for response and outcome.
@nl
P2093
P2860
P1476
Response assessment in metasta ...... kers for response and outcome.
@en
P2093
Anita Giobbie-Hurder
F Stephen Hodi
Mizuki Nishino
Nikhil H Ramaiya
P2860
P2888
P356
10.1186/S40425-014-0040-2
P577
2014-11-18T00:00:00Z
P5875
P6179
1022897953